13F-HR filed by Invus Financial Advisors, LLC
Invus Financial Advisors, LLC filed this 13F-HR for the quarter ended 2023-09-30, filed 2023-11-14, with 8 holding rows worth $159,551,210.
- Accession
- 0001214659-23-015100
- Filer
- CIK 1802978
- Filed
- 2023-11-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q3 2023
A holdings report, 8 entries on the cover page, a total value of $159,551,210 stated on the cover page (in dollars after the unit check, H1), rows summing to $159,551,210 with VALUE read as dollars as filed, 13F file number 028-19938. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| NU HLDGS LTD | G6683N103 | ORD SHS CL A | 5,582,950 | $40,476,388 | dollars as filed | |
| TABOOLA.COM LTD | M8744T106 | ORD SHS | 9,969,495 | $37,784,386 | dollars as filed | |
| ARCUS BIOSCIENCES INC | 03969F109 | COM | 1,612,077 | $28,936,782 | dollars as filed | |
| COUPANG INC | 22266T109 | CL A | 1,635,947 | $27,811,099 | dollars as filed | |
| IONQ INC COM | 46222L108 | Stock | 500,000 | $7,440,000 | dollars as filed | |
| ORIC PHARMACEUTICALS INC | 68622P109 | COM | 1,007,575 | $6,095,829 | dollars as filed | |
| NOVOCURE LTD | G6674U108 | ORD SHS | 350,884 | $5,666,777 | dollars as filed | |
| IHS HOLDING LIMITED | G4701H109 | ORD SHS | 962,153 | $5,339,949 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001214659-23-015100 | this filing | 2023-11-14 | acceptance time not in the bulk data set |